Product code OQY— Obstetrics/Gynecology
Jada System
- Classification name
- Intrauterine Tamponade Balloon
- Device class
- Class 2
- Regulation
- 21 CFR 884.4530
- Advisory panel
- Obstetrics/Gynecology
- Total cleared
- 11
- First cleared
- Most recent
FDA classification definition
“provides temporary control or reduction of postpartum uterine bleeding”
Market context for product code OQY
FDA has cleared devices under product code OQY between 2010 and 2026, filed by 8 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.
Clearances per year
- 2026
- 2023
- 2022
- 2021
- 2020
- 2019
- 2017
- 2016
- 2015
- 2011
- 2010
Top applicants under product code OQY
Adverse events under product code OQY
product code OQY- Death
- 8
- Injury
- 616
- Malfunction
- 500
- Total
- 1,124
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Recent clearances under product code OQY
- K253642 — Jada System (Jada-2002)
- K230849 — ELLAVI UBT
- K223098 — Bakri Essential Postpartum Balloon
- K212757 — Jada System
- K201199 — Jada System
- K191264 — Every Second Matters-Uterine Balloon Tamponade (ESM-UBT)
- K170622 — Bakri Postpartum Balloon, Bakri Postpartum Balloon with Rapid Instillation Component
- K153591 — ebb Complete Tamponade System
- K150573 — ebb Complete Tamponade System
- K101535 — BT-CATH
- K091958 — BELFORT-DILDY OBSTETRIC TAMPONADE SYSTEM
Data sourced from openFDA. This site is unofficial and independent of the FDA.